[Two cases of non-curatively resected scirrhous gastric cancer that responded well to weekly paclitaxel therapy].
We report 2 cases in which the weekly administration of paclitaxel proved to be effective for patients with scirrhous gastric cancer who underwent a curability C operation. Weekly paclitaxel therapy was observed to effectively treat peritoneal and retroperitoneal dissemination. After this treatment the tumor markers decreased markedly. This weekly paclitaxel therapy was observed to cause no adverse effects, and thanks to the treatment the patients were able to consume normal meals. These patients could also be sufficiently treated as outpatients. Weekly paclitaxel therapy is thus considered to be effective for the treatment of advanced scirrhous gastric cancer with peritoneal and retroperitoneal dissemination.
Suto
Ryuichiro
R
Dept. of Surgery, Yamaguchi Prefecture Hospital.
Nakafuji
Yoshito
Y
Mochizuki
Kyoko
K
Oka
Kazunori
K
Jinbo
Mitsutaka
M
Chiba
Fumihiro
F
Moriuchi
Hiroki
H
Ikeda
Yuji
Y
Nawata
Sumihiko
S
Zempo
Nobuya
N
Kurata
Satoru
S
Nakayasu
Kiyoshi
K
Esato
Kensuke
K
Kamei
Toshiaki
T
D002293:Adenocarcinoma, Scirrhous / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage*; D010534:Peritoneal Neoplasms / Q000556:secondary; D011182:Postoperative Care; D011788:Quality of Life; D012186:Retroperitoneal Neoplasms / Q000556:secondary; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel